Article Details
Retrieved on: 2021-07-27 17:03:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The company is also developing UX053, in addition to other mRNA therapies, for indications currently undisclosed to the public. The development of the ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here